NO865333L - Fremgangsmaate og blanding for molekylvektbestemmelse av proteiner. - Google Patents
Fremgangsmaate og blanding for molekylvektbestemmelse av proteiner.Info
- Publication number
- NO865333L NO865333L NO865333A NO865333A NO865333L NO 865333 L NO865333 L NO 865333L NO 865333 A NO865333 A NO 865333A NO 865333 A NO865333 A NO 865333A NO 865333 L NO865333 L NO 865333L
- Authority
- NO
- Norway
- Prior art keywords
- molecular weight
- proteins
- protein
- mixture
- components
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims description 69
- 108090000623 proteins and genes Proteins 0.000 title claims description 69
- 238000000034 method Methods 0.000 title claims description 37
- 239000000203 mixture Substances 0.000 claims description 31
- 238000001514 detection method Methods 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 12
- 238000012546 transfer Methods 0.000 claims description 11
- 229920002401 polyacrylamide Polymers 0.000 claims description 10
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 108060003951 Immunoglobulin Proteins 0.000 claims description 9
- 102000018358 immunoglobulin Human genes 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 9
- 229940072221 immunoglobulins Drugs 0.000 claims description 6
- 229940027941 immunoglobulin g Drugs 0.000 claims description 5
- 238000009826 distribution Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 50
- 239000000499 gel Substances 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 241000282414 Homo sapiens Species 0.000 description 13
- 108010074605 gamma-Globulins Proteins 0.000 description 12
- 241000894007 species Species 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 8
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 238000001262 western blot Methods 0.000 description 7
- 241000588832 Bordetella pertussis Species 0.000 description 6
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 229920001220 nitrocellulos Polymers 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 241000283707 Capra Species 0.000 description 4
- 201000005702 Pertussis Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 208000002109 Argyria Diseases 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 101710154643 Filamentous hemagglutinin Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- BQWBEDSJTMWJAE-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-[(2-iodoacetyl)amino]benzoate Chemical compound C1=CC(NC(=O)CI)=CC=C1C(=O)ON1C(=O)CCC1=O BQWBEDSJTMWJAE-UHFFFAOYSA-N 0.000 description 1
- SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010032597 Cohn fraction II Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010081690 Pertussis Toxin Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- -1 diazophenylthio Chemical group 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- ZLFRJHOBQVVTOJ-UHFFFAOYSA-N dimethyl hexanediimidate Chemical compound COC(=N)CCCCC(=N)OC ZLFRJHOBQVVTOJ-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
- G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH038185 | 1985-05-01 | ||
| PCT/AU1986/000118 WO1986006383A1 (en) | 1985-05-01 | 1986-04-30 | Molecular weight determination of proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO865333L true NO865333L (no) | 1986-12-30 |
Family
ID=3771078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO865333A NO865333L (no) | 1985-05-01 | 1986-12-30 | Fremgangsmaate og blanding for molekylvektbestemmelse av proteiner. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0221116A4 (da) |
| JP (1) | JPS63500207A (da) |
| CA (1) | CA1272938A (da) |
| DK (1) | DK634486A (da) |
| NO (1) | NO865333L (da) |
| NZ (1) | NZ215967A (da) |
| WO (1) | WO1986006383A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19729248C1 (de) * | 1997-07-09 | 1998-07-09 | Jochen Uhlenkueken | Standardprotein |
| JP3432158B2 (ja) * | 1998-12-04 | 2003-08-04 | 日立ソフトウエアエンジニアリング株式会社 | 電気泳動方法、電気泳動装置及びそれに用いるマーカー試料 |
| AU6608500A (en) * | 1999-07-27 | 2001-02-13 | Bio-Rad Laboratories, Inc. | Automated landmarking for two-dimensional electrophoresis |
| DE10244502B4 (de) * | 2002-09-25 | 2006-06-01 | Universität Gesamthochschule Kassel | Molekulargewichtsmarker für Proteine und Verfahren zu dessen Herstellung |
| EP3892989A1 (en) * | 2020-04-07 | 2021-10-13 | Ares Trading S.A. | Capillary gel electrophoresis and its use with complex biological molecules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5292590A (en) * | 1976-01-30 | 1977-08-04 | Oriental Yeast Co Ltd | Isoelectric point marker for separation of isoelectric points of gel |
| JPS55153724A (en) * | 1979-05-17 | 1980-11-29 | Teijin Ltd | Preparation of immunoglobulin derivative |
| WO1980002561A1 (en) * | 1979-05-23 | 1980-11-27 | Teijin Ltd | Process for preparing immune ypsilon-globulin derivative |
| US4681848A (en) * | 1982-09-22 | 1987-07-21 | Takeda Chemical Industries, Ltd. | Novel peptide and use thereof |
| CA1260828A (en) * | 1983-07-04 | 1989-09-26 | Masakazu Iwai | Therapeutic and prophylactic agent for gastrointestinal ulcers |
-
1986
- 1986-04-28 NZ NZ21596786A patent/NZ215967A/en unknown
- 1986-04-30 EP EP19860902779 patent/EP0221116A4/en not_active Ceased
- 1986-04-30 JP JP50259186A patent/JPS63500207A/ja active Pending
- 1986-04-30 WO PCT/AU1986/000118 patent/WO1986006383A1/en not_active Application Discontinuation
- 1986-04-30 CA CA000508010A patent/CA1272938A/en not_active Expired
- 1986-12-30 NO NO865333A patent/NO865333L/no unknown
- 1986-12-30 DK DK634486A patent/DK634486A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986006383A1 (en) | 1986-11-06 |
| EP0221116A1 (en) | 1987-05-13 |
| EP0221116A4 (en) | 1987-09-15 |
| JPS63500207A (ja) | 1988-01-21 |
| NZ215967A (en) | 1988-05-30 |
| CA1272938A (en) | 1990-08-21 |
| DK634486D0 (da) | 1986-12-30 |
| DK634486A (da) | 1987-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Edelman et al. | Immunological studies of human γ-globulin: Relation of the precipitin lines of whole γ-globulin to those of the fragments produced by papain | |
| Marchalonis et al. | Phylogenetic Origins of Antibody Structure: I. Multichain Structure of Immunoglobulins in the Smooth Dogfish (Mustelus Canis) | |
| Ahle et al. | Purification and properties of a new clathrin assembly protein. | |
| Curtiss et al. | A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. | |
| US7344848B2 (en) | Methods for determining adequacy of heat processing of a cooked meat sample | |
| Marchalonis | Isolation and partial characterization of immunoglobulins of goldfish (Carassius auratus) and carp (Cyprinus carpio) | |
| White et al. | Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes | |
| Langeland | A Clinical and Immunological Study of Allergy to Hen's Egg White: II, Antigens in Hen's Egg White Studied by Crossed Immunoelectrophoresis (CIE) | |
| Fitzgerald | Immunochemical characterization of a Mr 115 lens fiber cell-specific extrinsic membrane protein | |
| DK169571B1 (da) | Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåder til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof | |
| Alexander et al. | Characterization of membrane and cytoplasmic antigens of Mycoplasma arginini by two-dimensional (crossed) immunoelectrophoresis | |
| NO865333L (no) | Fremgangsmaate og blanding for molekylvektbestemmelse av proteiner. | |
| EP0585960A2 (en) | Diagnostic method for autoimmune diseases | |
| Chiang et al. | Collagen-platelet interaction: separate receptor sites for types I and III collagen | |
| US6423506B1 (en) | Monoclonal antibodies specific to cooked meats | |
| WO1998008371A9 (en) | Monoclonal antibodies specific to cooked meats | |
| Mather et al. | Detection of xanthine oxidase and immunologically related proteins in fractions from bovine mammary tissue and milk after electrophoresis in polyacrylamide gels containing sodium dodecyl sulphate | |
| Schiefer et al. | Immunological studies on the localization of phosphatidylglycerol in the membranes of Mycoplasma hominis | |
| Stylos et al. | Splitting of human thyroglobulin. II. Enzymatic digestion | |
| Morrison-Plummer et al. | An ELISA to detect monoclonal antibodies specific for lipid determinants of Mycoplasma pneumoniae | |
| Billett et al. | The use of a poultry‐specific murine monoclonal antibody directed to the insoluble muscle protein desmin in meat speciation | |
| Bassett et al. | STUDIES ON HUMAN ANTIBODIES: III. Amino Acid Composition of Four Antibodies from One Individual | |
| Watanabe et al. | Serologic and immunochemical characterization of an immunosuppressive soluble factor from mastocytoma-bearing mice | |
| Castellá et al. | Immunological properties of rat phosphoglycerate mutase isozymes | |
| NO173104B (no) | Monoklonalt antistoff til selektiv immunologisk bestemmelse av intakt prokollagenpeptid (type iii) og prokollagen (type iii), en hybridoma cellelinje som produserer dette antistoff samt et preparat inneholdende antistoffet |